Foundation for Sarcoidosis Research Launches the Coalition
Foundation for Sarcoidosis Research Launches the Coalition for Clinical Trial Equity to Address Barriers Faced by Black Patients...
Source: globenewswire.com
📰 Kinevant Sciences News
Kinevant Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Kinevant Sciences. Real-time updates on events, politics, business and more.
Chronic Lower Back Pain Market to Showcase Tremendous Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - Eli Lilly, Camurus, Braeburn Inc., Scilex Holding, Mesoblast Limited, AnGes MG
/PRNewswire/ -- DelveInsights Chronic Lower Back Pain Market Insights report includes a comprehensive understanding of current treatment practices, chronic...
Source: prnewswire.com
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis
These 2 randomized clinical trials compare the efficacy and safety of 2 doses of the autotaxin inhibitor ziritaxestat vs placebo in patients with idiopathic pul
Source: jamanetwork.com
FOUNDATION FOR SARCOIDOSIS RESEARCH LAUNCHES ITS FIRST-EVER CLINICAL TRIAL EQUITY INITIATIVE FOR BLACK AND AFRICAN AMERICANS
/PRNewswire/ -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the launch of the Ignore No More: ACTe Now! (Advance Clinical Trials for...
United States Mary Mcgowan Jeryl Prescott Gallien Evita Mcdaniels No More Campaign Mallinckrodt Pharmaceuticals
Source: prnewswire.com
FOUNDATION FOR SARCOIDOSIS RESEARCH LAUNCHES ITS FIRST-EVER CLINICAL TRIAL EQUITY INITIATIVE FOR BLACK AND AFRICAN AMERICANS
/PRNewswire/ -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the launch of the Ignore No More: ACTe Now! (Advance Clinical Trials for...
United States Mary Mcgowan Jeryl Prescott Gallien Evita Mcdaniels No More Campaign Mallinckrodt Pharmaceuticals
Source: prnewswire.com